Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation

Correction for ‘Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation’ by Sunil Kumar et al., RSC Adv., 2023, 13, 9513–9529, https://doi.org/10.1039/D3RA00526G.

Detalles Bibliográficos
Autores principales: Kumar, Sunil, Manoharan, Amritha, J, Jayalakshmi, Abdelgawad, Mohamed A., Mahdi, Wael A., Alshehri, Sultan, Ghoneim, Mohammed M., Pappachen, Leena K., Zachariah, Subin Mary, Aneesh, T. P., Mathew, Bijo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2023
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077342/
https://www.ncbi.nlm.nih.gov/pubmed/37033440
http://dx.doi.org/10.1039/d3ra90030d
Descripción
Sumario:Correction for ‘Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation’ by Sunil Kumar et al., RSC Adv., 2023, 13, 9513–9529, https://doi.org/10.1039/D3RA00526G.

Ejemplares similares